Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Citigroup

CVS Health

Investing in the stock market under the current economic uncertainties can be confusing and risky. However, looking for companies with a proven growth and stability track record is a prudent place to start searching for investment opportunities regardless of the macroeconomic situation.

3 Stocks With Proven Growth Records

Viatris

Continued Medicaid expansion bodes well for Centene. Viatris' drug pipeline should deliver modest growth in the years ahead.

Wall Street Thinks These 2 Value Stocks Could Soar

Fred Eppinger to assume role of Chairman of the Centene Board Wayne DeVeydt to assume role of Chairman of the Audit and Compliance Committee Orlando Ayala, Richard Gephardt and William Trubeck to retire from the Board effective May 10, 2023 ST. LOUIS , April 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Fred Eppinger will assume the role of Chairman of the Centene Board of Directors, and Wayne DeVeydt will assume the role of Chairman of the Audit and Compliance Committee.

CENTENE ANNOUNCES CHANGES TO BOARD OF DIRECTORS

ST. LOUIS , March 31, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that it will release its 2023 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 25, 2023, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2023 FIRST QUARTER FINANCIAL RESULTS CONFERENCE CALL

ST. LOUIS , March 31, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has been named one of America's Most Innovative Companies by Fortune magazine. Centene is one of 300 companies included on the inaugural list.

CENTENE RECOGNIZED BY FORTUNE AS ONE OF "AMERICA'S MOST INNOVATIVE COMPANIES"

Centene (CNC) expands the use of Evolent's oncology specialty care to improve cost management.

Centene (CNC) Expands Evolent Partnership to Boost Quality

Health Net Assisting Members in Alameda, Marin, Modoc and Shasta Counties During State of Emergency SACRAMENTO, Calif. , March 29, 2023 /PRNewswire/ -- In response to Gov.

Health Net Providing Special Assistance to Members Affected by Winter Storms

Evolent Health

WASHINGTON , March 29, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC).  Centene will expand its use of Evolent Health's oncology solution across its Centene and WellCare Medicare Advantage (MA) members nationally.

Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members

ST. LOUIS , March 27, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today the appointment of Tanya McNally to Senior Vice President and Chief People Officer of Centene. As the Chief People Officer, Ms.

CENTENE CORPORATION ANNOUNCES NEW CHIEF PEOPLE OFFICER

Cigna

Humana

Molina Healthcare

UnitedHealth Group

Improved premiums cropping from a solid customer base might aid the Medical-HMO industry. However, an escalating expense level and an acute shortage of nurses are roadblocks.

5 HMO Stocks to Watch Despite Elevated Tech Costs, Nursing Shortage

Shares of government insurance giant Centene Corporation are down a third from their all-time high set in August 2022 as a series of potential headwinds await. Amongst them are the return of Medicaid eligibility redeterminations and a confluence of negative events surrounding Medicare Advantage.

Centene: A 'Check Down' Play

Airbnb

Align Technology

Coinbase

ConocoPhillips

Charles River Laboratories

Corteva Inc

DuPont de Nemours

Dell Technologies

Disney

Dow Inc

Devon Energy

Energy Transfer LP Unit

Forward Air

Herbalife

Intel

John B. Sanfilippo & Son

Keurig Dr Pepper Inc

Lyft

Markel

Microsoft

NextEra Energy

Insight Enterprises

New York Community Bancorp

The month of February had a couple of very interesting insider purchases. In this article, we discuss the 10 biggest insider purchases by value. In addition, we will take a look into 2 companies more in-depth, which we found particularly interesting this month.

Top Insider Picks For February 2023

ST. LOUIS , March 2, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Barclays 2023 Global Healthcare Conference, to be held Tuesday, March 14-Thursday, March 16,  2023, in Miami Beach, Florida. Centene will present on Tuesday, March 14 th at 9:00 a.m.

CENTENE TO PRESENT AT BARCLAYS 2023 GLOBAL HEALTHCARE CONFERENCE

Centene Charitable Foundation Sponsored National No One Eats Alone® Day for Seventh Consecutive Year Health Plans Hosted Events in 220 Schools across the Country in 2023 ST. LOUIS , Feb. 23, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today the Centene Charitable Foundation sponsored National No One Eats Alone® Day on Feb. 17.

Centene Addresses Social Isolation in Schools with National No One Eats Alone Day

This company is one of the biggest health insurers in the United States.

This Blue Chip Bargain Stock Is a Strong Buy for Growth Investors

Amazon

Match Group

Snowflake

Some quality stocks are on sale, a perfect opportunity for investors interested in names that might have a particularly bright future.

Amazon and Other Quality Stocks Have Been Hit Hard. They Could Be Buys.

Funds will establish programs to prepare new street medicine workforces across the state. SACRAMENTO, Calif.

Health Net Awards $1.5 Million Grant to Keck School of Medicine to Enable Street Medicine Teams to Better Serve Unsheltered Populations Across California

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Centene (CNC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Centene's (CNC) fourth-quarter results suffer from elevated medical expenses, partly offset by growing premium and service revenues.

Centene (CNC) Q4 Earnings Miss on High Costs, '23 Premium View Up

Centene Corp (NYSE:CNC ) Q4 2022 Earnings Conference Call February 7, 2023 8:30 AM ET Company Participants Sarah London - CEO & Director Jennifer Gilligan - SVP, IR Kenneth Fasola - President James Murray - EVP & COO Andrew Asher - EVP & CFO Conference Call Participants Joshua Raskin - Nephron Research Stephen Baxter - Wells Fargo Securities Justin Lake - Wolfe Research A.J. Rice - Crédit Suisse Scott Fidel - Stephens Calvin Sternick - JPMorgan Chase & Co. Gary Taylor - Cowen and Company Steven Valiquette - Barclays Bank Kevin Fischbeck - Bank of America Merrill Lynch Michael Ha - Morgan Stanley George Hill - Deutsche Bank Nathan Rich - Goldman Sachs Group Operator Good day, and welcome to the Centene Fourth Quarter Earnings Conference Call.

Centene Corp (CNC) Q4 2022 Earnings Call Transcript

Centene (CNC) delivered earnings and revenue surprises of -1.15% and 0.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Q4 Earnings and Revenues Lag Estimates

Centene Corp. CNC, swung to a loss in the latest quarter, though the company boosted its 2023 revenue forecast in its Tuesday morning report. The company posted a fourth-quarter net loss of $213 million, or 38 cents a share, whereas it generated net income of $599 million, or $1.01 a share, in the year-earlier quarter.

Centene boosts revenue forecast for 2023

-- 2022  Full Year Diluted EPS of $2.07; Adjusted Diluted EPS of $5.78 -- 2022 adjusted diluted EPS growth of 12%. 2022 total revenues of $144.5 billion, up 15%.

CENTENE CORPORATION REPORTS 2022 RESULTS

AbbVie

Baxter

BeiGene

Exact Sciences

GE HealthCare Technologies Inc

IDEXX Laboratories

Neurocrine Biosciences

Pfizer

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022.

5 Best and Worst Performing Healthcare Stocks in January 2023

ST. LOUIS , Feb. 6, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has been named to the 2023 Bloomberg Gender-Equality Index for the fourth year. The annual index recognizes companies for their policies and practices in support of women in the workforce across five pillars: leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, anti-sexual harassment policies and external brand.

News for Centene Stock (CNC)